Dynamic signaling by intracellular hormone receptors

细胞内激素受体的动态信号传导

基本信息

项目摘要

The long-term objectives of this project are to understand the purpose of dynamic transcription complexes and the mechanisms that promote dissociation of the employed structures. ¿The general strategy to be used is to focus on intracellular hormone receptor (IR) mediated transcription, which uses a series of proteins to reach a functional endpoint, and to study the requirement for active disassembly of the recruited complexes. For example, following hormone binding IRs nucleate multiple structures at genomic response elements whose coordinated actions lead to the production of specific mRNA transcripts. Though the complexes are long-lived in vitro, in vivo the structures are highly dynamic (t1/2 < 4 sec). The rapid IR kinetics may facilitate efficient transitions between the employed proteins and may permit effective sensing of hormone levels by IRs¿defects in these activities may contribute to a myriad of diseases. Hence, dynamic action is a critical feature for IR signal transduction. The proposed studies will focus on the roles of molecular chaperones in promoting IR transduction pathways including conveying the signal through transcription structures and reacting to changes in hormone levels. ¿To address the premise that the p23 and Hsp90 molecular chaperones alter the DNA binding state of select transcription factors including IRs and that certain coactivators can stabilize the DNA bound statethree goals are envisioned: 1) Determine the mechanism of chaperone-promoted transcription factor dynamics; 2) Examine the chaperone-mediated transitions between transcription complexes; 3) Study the effect of cofactors on GR-nucleated transcription. ¿Gene regulation, particularly events modulated by IRs, has been implicated in a wide range of diseases including cancer, inflammation and hypertension; many of these diseases can be controlled using ligands to IRs. Imperative for the use of IR ligands as therapeutic agents, is an appropriate and timely response by the cognate receptor to ligand application and withdrawal. Thus, understanding the mechanisms that govern gene regulation by IRs, particularly events that dictate response times, has important implications for health, and for detecting, treating, and curing disease.
这个项目的长期目标是了解动态转录复合体的目的 以及促进所用结构解离的机制。 使用的一般策略是关注细胞内激素受体(IR)介导的转录, 它使用一系列蛋白质来达到功能终点,并研究活性蛋白质的需求。 分解所募集的复合物。例如,在激素结合IR之后, 基因组反应元件的结构,其协调作用导致产生特定的 mRNA转录物。虽然复合物在体外是长寿命的,但在体内结构是高度动态的 (t1/2 < 4秒)。快速IR动力学可促进所用蛋白质之间的有效转变, 可能允许IR有效地感知激素水平,这些活动的缺陷可能有助于 无数的疾病。因此,动态作用是IR信号转导的关键特征。拟议 研究将集中在分子伴侣在促进IR转导途径中的作用, 通过转录结构传递信号并对激素水平的变化做出反应。 为了解决p23和Hsp 90分子伴侣改变DNA结合状态的前提, 选择包括IR在内的转录因子,某些辅激活因子可以稳定DNA结合 本论文的研究目标有三:1)确定分子伴侣促进转录因子的作用机制 动力学; 2)检查转录复合物之间的伴侣介导的转换; 3)研究 辅助因子对GR核转录的影响。 基因调控,特别是由IR调节的事件,与广泛的疾病有关。 包括癌症、炎症和高血压;这些疾病中的许多都可以用配体来控制 到IR。对于IR配体作为治疗剂的使用来说,当务之急是适当和及时的反应, 同源受体对配体的应用和撤回。因此,了解 通过IR控制基因调节,特别是决定反应时间的事件,具有重要的意义 用于健康,用于检测,治疗和治愈疾病。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
HSP90 manages the ends.
  • DOI:
    10.1016/j.tibs.2010.02.005
  • 发表时间:
    2010-07
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    DeZwaan, Diane C.;Freeman, Brian C.
  • 通讯作者:
    Freeman, Brian C.
Global functional map of the p23 molecular chaperone reveals an extensive cellular network.
  • DOI:
    10.1016/j.molcel.2011.05.029
  • 发表时间:
    2011-07-22
  • 期刊:
  • 影响因子:
    16
  • 作者:
    Echtenkamp FJ;Zelin E;Oxelmark E;Woo JI;Andrews BJ;Garabedian M;Freeman BC
  • 通讯作者:
    Freeman BC
The p23 molecular chaperone and GCN5 acetylase jointly modulate protein-DNA dynamics and open chromatin status.
  • DOI:
    10.1016/j.molcel.2012.08.026
  • 发表时间:
    2012-11-09
  • 期刊:
  • 影响因子:
    16
  • 作者:
    Zelin, Elena;Zhang, Yang;Toogun, Oyetunji A.;Zhong, Sheng;Freeman, Brian C.
  • 通讯作者:
    Freeman, Brian C.
Is there a telomere-bound 'EST' telomerase holoenzyme?
  • DOI:
    10.4161/cc.9.10.11536
  • 发表时间:
    2010-05-15
  • 期刊:
  • 影响因子:
    4.3
  • 作者:
    DeZwaan, Diane C.;Freeman, Brian C.
  • 通讯作者:
    Freeman, Brian C.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian C Freeman其他文献

Brian C Freeman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian C Freeman', 18)}}的其他基金

Regulation of the Native Protein Landscape in the Nucleus by Molecular Chaperones
分子伴侣对细胞核中天然蛋白质景观的调节
  • 批准号:
    10641829
  • 财政年份:
    2020
  • 资助金额:
    $ 8.99万
  • 项目类别:
Regulation of the Native Protein Landscape in the Nucleus by Molecular Chaperones
分子伴侣对细胞核中天然蛋白质景观的调节
  • 批准号:
    10244899
  • 财政年份:
    2020
  • 资助金额:
    $ 8.99万
  • 项目类别:
Regulation of the Native Protein Landscape in the Nucleus by Molecular Chaperones
分子伴侣对细胞核中天然蛋白质景观的调节
  • 批准号:
    10437868
  • 财政年份:
    2020
  • 资助金额:
    $ 8.99万
  • 项目类别:
2019 Stress Proteins in Growth, Development, and Disease GRC/GRS
2019 生长、发育和疾病 GRC/GRS 中的应激蛋白
  • 批准号:
    9762269
  • 财政年份:
    2019
  • 资助金额:
    $ 8.99万
  • 项目类别:
The Hsp90 molecular chaperone system
Hsp90分子伴侣系统
  • 批准号:
    8660046
  • 财政年份:
    2011
  • 资助金额:
    $ 8.99万
  • 项目类别:
The Hsp90 molecular chaperone system
Hsp90分子伴侣系统
  • 批准号:
    8300088
  • 财政年份:
    2011
  • 资助金额:
    $ 8.99万
  • 项目类别:
The Hsp90 molecular chaperone system
Hsp90分子伴侣系统
  • 批准号:
    9256500
  • 财政年份:
    2011
  • 资助金额:
    $ 8.99万
  • 项目类别:
The Hsp90 molecular chaperone system
Hsp90分子伴侣系统
  • 批准号:
    8460165
  • 财政年份:
    2011
  • 资助金额:
    $ 8.99万
  • 项目类别:
The Hsp90 molecular chaperone system
Hsp90分子伴侣系统
  • 批准号:
    8186164
  • 财政年份:
    2011
  • 资助金额:
    $ 8.99万
  • 项目类别:
Dynamic signaling by intracellular hormone receptors
细胞内激素受体的动态信号传导
  • 批准号:
    7368614
  • 财政年份:
    2006
  • 资助金额:
    $ 8.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了